James R. Lupski
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (20)
While most individuals with familial medullary thyroid carcinoma (fMTC) carry RET mutations, in some instances the causative mutations remain unknown. We studied two related families with RET-negative fMTC in 21 affected individuals through linkage analysis, exome/genome sequencing, and high-density array comparative genomic hybridization. We identified a novel heterozygous 40kb intragenic SLC30A9 deletion which segregated with the disease in all affected individuals. The mutant transcript escaped nonsense-mediated decay and resulted in the production of N-terminally truncated proteins via translation reinitiation from in-frame AUG codons located downstream of the deletion. These proteins showed increased stability and their expression in an MTC cell line increased cell proliferation and clonogenic capacity, supporting an oncogenic role. These findings expand the genetic background of fMTC beyond RET mutations and implicate translation reinitiation in the etiology of cancer susceptibility syndromes secondary to structural genomic variants.
Year:
2026
Dysfunction at the centrosome-cilium interface underlies a broad range of ciliopathies. Here, we identify biallelic variants in CEP76 , encoding a centrosomal protein, in eight unrelated individuals presenting with neurodevelopmental, ocular, and variable additional multisystem features. Proband-derived fibroblasts and CEP76-depleted RPE1 cells display ciliary deficits, including impaired cilium formation and length, disrupted transition zone architecture, and impaired IFT88-mediated anterograde intraflagellar transport. Zebrafish cep76 mutants recapitulate key clinical phenotypes, and in vitro complementation assays confirm pathogenicity for all tested human disease-associated variants. Proteomics analysis identifies CEP76 interactors, including known partners CCP110 and CEP97, and highlights clinically and functionally relevant candidates, including ALMS1 and LUZP1. Together, these findings expand the role of CEP76 beyond centriole duplication to include ciliary assembly and trafficking, establishing it as a ciliopathy gene. This work provides mechanistic insights into CEP76 -related disease and broadens our understanding of centrosome-cilium biology.
Year:
2025
Year:
2025
TUBB2B encodes a β-tubulin isotype essential for neuronal proliferation, migration, and organization during brain development. Pathogenic heterozygous variants in TUBB2B have been associated with a range of neurodevelopmental disorders, with phenotypes including polymicrogyria and corpus callosum abnormalities. However, the phenotypic spectrum remains heterogeneous, likely influenced by variant-specific effects on microtubule formation and stability, an area that warrants further investigation. Homozygous TUBB2B variants are exceedingly rare, with one family reported to date. We describe five individuals in four families with rare TUBB2B variants. Four variant alleles are described, including a previously reported de novo missense variant p.(G98R), with potential phenotypic expansion including panhypopituitarism, a previously reported de novo missense variant, p.(I202T) demonstrating phenotypic heterogeneity between individuals, a de novo missense variant, p.(Q15K) at a polyamination site critical for microtubule stability, and a novel homozygous missense variant located within a region of absence of heterozygosity in two siblings from consanguineous parents p.(V49I). Both individuals also have a pathogenic homozygous truncating variant in ALKBH8 p.(R559Afs*56), representing a rare dual molecular diagnosis driving clinical features reflective of contributions from both genes. These cases expand the known clinical spectrum of TUBB2B -related tubulinopathies, illustrate intragenic phenotypic heterogeneity, including with recurrent variants and provide novel insights into potential mechanisms of disease, such as effects at polyamination sites and rare recessive inheritance, underscoring the need for nuanced genotype-phenotype interpretation in both diagnostic and counseling contexts.
Year:
2025
Poly(rC)-binding protein 1 (PCBP1), a splicing factor and key member of the hnRNP E family, was initially characterized for its tumor suppressive properties. More recently, its role in regulating gene expression in the brain and nervous system has attracted growing interest. Through an international multicenter collaboration, we identified 13 de novo pathogenic variants in PCBP1 across 13 unrelated families. All affected individuals exhibited intellectual disability (ID), with autism spectrum disorder (ASD) as a prominent feature. Functional analysis in primary hippocampal mouse neuron cultures demonstrated that PCBP1 variants impair dendritic arborization, underscoring their deleterious effects. Transcriptomic profiling by RNA sequencing of subjects-derived T cells showed a distinctive signature characterized by significantly increased exon skipping. These results highlight the essential role of PCBP1 in neurogenesis and neuritogenesis, revealing the impact of loss-of-function variants in cells harboring PCBP1 pathogenic variants, thereby confirming the link between splicing defects and neurodevelopmental disorders. Collectively, our findings demonstrate the critical role of PCBP1 in neurodevelopment, reaffirming the importance of splicing regulation in mammalian neurodevelopment.
Year:
2025
Nonsense-mediated decay (NMD) as an RNA-surveillance pathway degrades transcripts with variants introducing premature termination codons (i.e., PTC-variants), yet a substantial subset of pathogenic PTC-variants downstream of the final exon–exon junction is predicted to escape NMD (NMD-escape) based on the canonical 50-bp rule. Our systematic analysis of germline pathogenic PTC-variants from ClinVar revealed 148 autosomal dominant (AD) disease genes enriched for predicted NMD-escape alleles. These genes span nonsense (N=63), −1 frameshift (N=34), and +1 frameshift (N=22) variants, with 23 genes enriched for two classes and 6 for all three. Although their loss-of-function intolerance score distributions did not differ from controls (P = 0.407), these genes exhibited significantly higher protein–protein interaction (PPI) network centrality (P < 0.05) with their NMD-escape regions enriched for PPI interfaces (P < 0.001 for −1 and nonsense) and low-complexity sequences (P < 0.03 for −1 and +1). P/LP variants also produced significantly longer mutant C-terminal tails than controls (P < 0.01), increasing potential for functional disruption. Structural modeling of altered C-terminal tails revealed recurrent gains of glycine/proline (P < 0.03) and changes in aromatic residue content consistent with altered intrinsic disorder. Integration with neurodevelopmental disorder gene sets identified 25 dosage-sensitive genes with predicted NMD-escape P/LP variants, seven (28%) encoding condensate-forming proteins. Variant-level modeling in representative genes (e.g., KAT6B ) showed altered phase-separation propensity driven by truncated and/or altered intrinsically disordered regions. Overall, this study implicates condensate dysregulation as a potential downstream biophysical consequence of NMD-escape disease alleles, providing a protein-feature viewer for variant interpretation ( https://github.com/schmidtjacob46/NMDesc-protein-viewer ).
Year:
2025
Robinow syndrome (RS) is a genetically heterogeneous rare disorder involving six genes in the WNT/planar cell polarity (PCP) signaling pathway. Frameshifting variants in DVL genes that introduce a novel basic C-terminus are a common cause of dominant RS, accounting for ∼33% of individuals without ROR2 variants. Here, we investigated the cellular effects of pathogenic DVL frameshift variants with mutant tails of at least 82 amino acids. In silico analysis revealed altered intrinsically disordered regions (IDRs), charge distribution, and predicted structure. To explore their pathogenic mechanisms, we generated wild-type (WT), frameshift, and truncated constructs of DVL1 , DVL2 , and DVL3 , and analyzed their behavior in a transfection-based in vitro system. DVL proteins normally polymerize into cytoplasmic puncta that redistribute upon WNT stimulation. Immunocytochemistry showed that mutant DVL proteins failed to change their localization in response to WNT3A, in contrast to WT alleles—a consistent observation across all three DVLs. In line with this, TOPFlash reporter assays demonstrated that mutant DVL1 and DVL3 failed to activate canonical WNT signaling, while WT proteins induced strong activation. Additionally, the mutant C-terminal tail interfered with CSNK1E-induced phosphorylation, offering a potential mechanism underlying the impaired response. Our results provide further understanding of the cellular consequences of pathogenic DVL frameshifting variants and offers insights into the effects of such alleles on WNT signaling, and the perturbations thereof, that may lead to developmental phenotypes observed in RS.
Year:
2025
Idiopathic scoliosis (IS) is the most common form of spinal deformity with unclear pathogenesis. In this study, we firstly reanalyzed the loci associated with IS, drawing upon previous studies. Subsequently, we mapped these loci to candidate genes using either location-based or function-based strategies. To further substantiate our findings, we verified the enrichment of variants within these candidate genes across several large IS cohorts encompassing Chinese, East Asian, and European populations. Consequently, we identified variants in the EPHA4 gene as compelling candidates for IS. To confirm their pathogenicity, we generated zebrafish mutants of epha4a. Remarkably, the zebrafish epha4a mutants exhibited pronounced scoliosis during later stages of development, effectively recapitulating the IS phenotype. We observed that the epha4a mutants displayed defects in left-right coordination during locomotion, which arose from disorganized neural activation in these mutants. Our subsequent experiments indicated that the disruption of the central pattern generator (CPG) network, characterized by abnormal axon guidance of spinal cord interneurons, contributed to the disorganization observed in the mutants. Moreover, when knocked down efnb3b, the ligand for Epha4a, we observed similar CPG defects and disrupted left-right locomotion. These findings strongly suggested that ephrin B3-Epha4 signaling is vital for the proper functioning of CPGs, and defects in this pathway could lead to scoliosis in zebrafish. Furthermore, we identified two cases of IS in NGEF, a downstream molecule in the EPHA4 pathway. Collectively, our data provide compelling evidence that neural patterning impairments and disruptions in CPGs may underlie the pathogenesis of IS.
Year:
2025
Background Diagnosing rare genetic disorders relies on precise phenotypic and genotypic analysis, with the Human Phenotype Ontology (HPO) providing a standardized language for capturing clinical phenotypes. Traditional HPO tools, such as Doc2HPO and ClinPhen, employ concept recognition to automate phenotype extraction but struggle with incomplete phenotype assignment, often requiring intensive manual review. While large language models (LLMs) hold promise for more context-driven phenotype extraction, they are prone to errors and “hallucinations,” making them less reliable without further refinement. We present RAG-HPO, a Python-based tool that leverages Retrieval-Augmented Generation (RAG) to elevate LLM accuracy in HPO term assignment, bypassing the limitations of baseline models while avoiding the time and resource intensive process of fine-tuning. RAG-HPO integrates a dynamic vector database, allowing real-time retrieval and contextual matching. Methods The high-dimensional vector database utilized by RAG-HPO includes >54,000 phenotypic phrases mapped to HPO IDs, derived from the HPO database and supplemented with additional validated phrases. The RAG-HPO workflow uses an LLM to first extract phenotypic phrases that are then matched via semantic similarity to entries within a vector database before providing best term matches back to the LLM as context for final HPO term assignment. A benchmarking dataset of 120 published case reports with 1,792 manually-assigned HPO terms was developed, and the performance of RAG-HPO measured against existing published tools Doc2HPO, ClinPhen, and FastHPOCR. Results In evaluations, RAG-HPO, powered by Llama-3 70B and applied to a set of 120 case reports, achieved a mean precision of 0.84, recall of 0.78, and an F1 score of 0.80—significantly surpassing conventional tools (p<0.00001). False positive HPO term identification occurred for 15.8% (256/1,624) of terms, of which only 2.7% (7/256) represented hallucinations, and 33.6% (86/256) unrelated terms; the remainder of false positives (63.7%, 163/256) were relative terms of the target term. Conclusions RAG-HPO is a user-friendly, adaptable tool designed for secure evaluation of clinical text and outperforms standard HPO-matching tools in precision, recall, and F1. Its enhanced precision and recall represent a substantial advancement in phenotypic analysis, accelerating the identification of genetic mechanisms underlying rare diseases and driving progress in genetic research and clinical genomics.
Year:
2024
Laterality defects are defined by perturbations in the usual left-right asymmetry of organs. Due to low known genetic etiology of congenital heart disease (CHD) cases (less than 40%), we used a digenic model approach for the identification of contributing variants in known laterality defect genes (N = 115) in the exome/genome sequencing (ES/GS) data from individuals with clinically diagnosed laterality defects. The unsolved ES/GS data were analyzed from three CHD cohorts: Baylor College of Medicine-Genomics Research to Elucidate the Genetics of Rare Diseases (BCM-GREGoR; N = 247 proband ES), Gabriella Miller Kids First Pediatric Research program (Kids First; N = 158 trio GS), and Pediatric Cardiac Genomics Consortium (PCGC; N = 163 trio ES), and trans-heterozygous digenic variants were identified in 2.8% (inherited digenic variants in 0.4%), 8.2%, and 13.5% cases respectively, which was significantly higher as compared to 602 control trios provided by the 1000 Genomes Project (p = 0.001, 1.4e-07, and 8.9e-13, respectively). Trans-heterozygous digenic variants were also identified in 0.4%, and 1.4% cases with non-laterality CHD in Kids First and PCGC datasets, respectively, which was not statistically significant as compared to control trios ( p = 1, and 0.059, respectively). Altogether, in laterality cohorts, 23% of digenic pairs were in the same structural complex of motile cilia. Out of 39 unique digenic pairs in laterality CHD, 29 are more likely to be potential digenic hits as predicted by DiGePred tool. These findings provide further evidence that digenic epistatic interaction can contribute to the complex genetics of laterality defects.
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Collaborators (75)
Sharon E. Plon
Professor and Assistant Dean
Baylor College of Medicine
Manolis Fanto
Lecturer/Senior Lecturer
King’s College London
Carol Wise
Director, Division of Molecular Genetics
Texas Scottish Rite Hospital for Children
Hans Zempel
-
Stefan Barakat
Associate professor
Erasmus MC
Anne-Francoise Roux
Université de Montpellier
Carlo Dionisi-Vici
Head of the Division
Ospedale Pediatrico Bambino Gesù
Neil Jon Ingham
King’s College London
Manju A. Kurian
Professor of Neurogenetics
University College London
Federica Begalli
Lecturer in Endocrinology
Queen Mary University of London
Shaine Morris
Associate Professor
Baylor College of Medicine
William Foulkes
Full Professor
McGill University
Anne Slavotinek
-
Michael Duchen
Professor of Physiology
University College London
Richard Lewis
Professor
Baylor College of Medicine
Chikashi Terao
RIKEN
Nicolas GUEX
Head, Bioinformatics Competence Center
University of Lausanne
Marton Doleschall
senior scientist
Semmelweis University
Darius Ebrahimi-Fakhari
Boston Children's Hospital
Lisenka Vissers
Radboud University Medical Center
Reza Maroofian
-
Lea Starita
Research Assistant Professor
University of Washington
Horia Constantin Stanescu
University College London
Sissy Bassani
University of Zurich
Michael Witcher
Associate Professor
Lady Davis Institute for Medical Research
Henry Houlden
Professor of Neurogenetics
-
Alfredo Brusco
Full Professor in Medical Genetics
Università degli Studi di Torino
Maralyn Druce
-
Borut Peterlin
Head
-
Jolanta Krajewska
Associate Professor
Maria Sklodowska-Curie Institute - Oncology Center Gliwice Branch
Christian Iseli
Head of Bioinformatics Competence Center
École Polytechnique Fédérale de Lausanne
Anne Barlier
Aix-Marseille University
Florence Petit
Université de Lille
Erica Davis
Professor
Ann and Robert H Lurie Children's Hospital of Chicago
Maria Alevizaki
Professor of Endocrinology
National and Kapodistrian University of Athens
Felix Distelmaier
University Children's Hospital
Sabrina Chiloiro
Università Cattolica del Sacro Cuore Facoltà di Medicina e Chirurgia
Stéphane Bézieau
Université de Nantes
Márta Korbonits
Deputy Director of the William Harvey Research Institute
Queen Mary University of London
Donato Iacovazzo
NIHR Clinical Lecturer
Queen Mary University of London
Giovanna Ambrosini
Senior Scientist
EPFL (École Polytechnique Fédérale de Lausanne)
Frederic Laumonnier
Team Leader, Research Director
INSERM
Rami Abou Jamra
University Hospital Leipzig
Matias Wagner
Technical University of Munich
Christian Gilissen
Professor of Genome Bioinformatics
Universitair Medisch Centrum Utrecht
Mathias Gautel
Head
King’s College London
Saskia Koene
Radboud Universitair Medisch Centrum
Malgorzata Oczko-Wojciechowska
Head of Department/Ph.D
Maria Sklodowska-Curie National Research Institute of Oncology
Jes Mathiesen
University of Southern Denmark
Calvin Yip
Associate Professor
The University of British Columbia
Wendy Chung
Kennedy Family Professor
Boston Children's Hospital
Rebecca Buchert
Research Group Leader
Universitätsklinikum Tübingen
Jennifer Posey
Assistant Professor
Baylor College of Medicine
Marcello Scala
Researcher
University of Genoa
R Mihai
Oxford University Hospitals NHS Foundation Trust
Suvi Savola
Head of Oncogenetics
MRC-Holland
Andrew Fennell
Head of Clinical Genetics
Monash Health
Pawel Gawlinski
Professor
Institute of Mother and Child
Willow Coyote-Maestas
Assistant Professor
University of California, San Francisco
Carla Daniela Robles-Espinoza
Group Leader
National Autonomous University of Mexico
Frédéric Ebstein
Group Leader
Université de Nantes
Alexandre Reymond
University of Lausanne
Heinz Jungbluth
King’s College London
Patricia Dickson
Professor
Washington University in St. Louis
Yalda Jamshidi
Director Translational Genetics
St George’s, University of London
Eric Venner
Baylor College of Medicine
Irene Gallego Romero
Principal Research Fellow
University of Melbourne
Miklós Tóth
professor
Semmelweis University
Nan Wu
Assistant Professor
Baylor College of Medicine
Emily M Mace
Columbia University
Douglas Fowler
Professor
University of Washington
Hormos Salimi Dafsari
Max Planck Institute for Biology of Ageing
Ploski R
Medical University of Warsaw
Karen P. Steel
Professor of Sensory Function
King’s College London
Alan Rubin
Group Leader
University of Melbourne
Make your next move.
Prepare your application
Review drafts before you send them.